BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28412998)

  • 41. Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis.
    Scharenberg MA; Chiquet-Ehrismann R; Asparuhova MB
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1911-4. PubMed ID: 20816842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
    Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
    J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers.
    Jetten AM
    Trends Cancer; 2019 Sep; 5(9):547-557. PubMed ID: 31474360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
    Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
    Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
    Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
    Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The CALM-AF10 fusion is a rare event in acute megakaryoblastic leukemia.
    Greiner O; Bornhauser BC; Delabesse E; Ballerini P; Landman-Parker J; Bourquin JP
    Leukemia; 2007 Dec; 21(12):2568-9. PubMed ID: 17611559
    [No Abstract]   [Full Text] [Related]  

  • 47. Frequent detection of
    Chen Wongworawat Y; Eskandari G; Gaikwad A; Marcogliese AN; Ferguson LS; Brackett J; Punia JN; Elghetany MT; Kulkarni R; Rao PH; Ringrose J; Lopez-Terrada DH; Roy A; Curry CV; Fisher KE
    Leuk Lymphoma; 2023 Feb; 64(2):462-467. PubMed ID: 36346368
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
    Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
    Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network.
    Wheat JC; Steidl U
    Cancer Cell; 2017 Mar; 31(3):307-308. PubMed ID: 28292433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
    Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
    BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
    Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y
    Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High incidence of CALM-AF10 fusion and the identification of a novel fusion transcript in acute megakaryoblastic leukemia in children without Down's syndrome.
    Abdelhaleem M; Beimnet K; Kirby-Allen M; Naqvi A; Hitzler J; Shago M
    Leukemia; 2007 Feb; 21(2):352-3. PubMed ID: 17170719
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
    Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
    Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
    PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
    Le Q; Hadland B; Smith JL; Leonti A; Huang BJ; Ries R; Hylkema TA; Castro S; Tang TT; McKay CN; Perkins L; Pardo L; Sarthy J; Beckman AK; Williams R; Idemmili R; Furlan S; Ishida T; Call L; Srivastava S; Loeb AM; Milano F; Imren S; Morris SM; Pakiam F; Olson JM; Loken MR; Brodersen L; Riddell SR; Tarlock K; Bernstein ID; Loeb KR; Meshinchi S
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36136600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
    Lo KC; Chalker J; Strehl S; Neat M; Smith O; Dastugue N; Kearney L; Izraeli S; Kempski H; Cowell JK
    Br J Haematol; 2008 Sep; 142(6):934-45. PubMed ID: 18557744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.